CEOs of Merck and Johnson & Johnson to Appear Before Senate Committee to Address Drug Pricing Concerns

CEOs of Merck and Johnson & Johnson to Appear Before Senate Committee to Address Drug Pricing Concerns


Senator Bernie ​Sanders, ‌representing Vermont, and Senator Ed Markey, representing Massachusetts, held a news conference at the Capitol on Thursday, January‍ 25,​ 2024. They discussed the issuance of subpoenas for pharmaceutical company‌ CEOs to testify about drug prices. The CEOs of Merck​ and​ Johnson & Johnson have agreed to testify at an ⁣upcoming Senate hearing on high drug ‍prices in‌ the U.S., as part of efforts to reduce health-care costs⁢ for Americans. The hearing⁢ is scheduled for February 8 at ⁣10 a.m. ‍ET. The Senate Health, Education, Labor⁢ and Pensions Committee had planned to vote to subpoena J&J CEO Joaquin‍ Duato and Merck CEO ‍Robert Davis to testify after both executives declined earlier‌ requests to​ appear at the hearing. Meanwhile, Bristol Myers Squibb CEO Chris‍ Boerner and another unnamed ⁣pharmaceutical ⁤CEO agreed ‌to initial invitations…

2024-01-26 17:23:53
Article from merck-jj-ceos-agree-to-testify-in-senate-hearing-on-drug-prices-.html” target=”_blank” style=”color:blue” rel=”noopener”>www.cnbc.com

Exit mobile version